Maximize your thought leadership

Advocacy Group Launches Campaign Questioning 340B Drug Pricing Program's Accountability

TL;DR

Reforms to the 340B Drug Pricing Program offer hospitals a chance to increase revenue and improve financial stability.

ADAP Advocacy's 340B Project advocates for reforms to ensure the integrity and transparency of the nation's second largest federally sponsored drug program.

The '340B Too Big To Fail' national advocacy campaign aims to address declining charity, rising healthcare executive compensation, and increasing patient medical debt for a better healthcare system.

ADAP Advocacy's new commercial highlights the need for common-sense reforms in the 340B Drug Pricing Program, drawing parallels to the financial market collapse in 2007-08.

Found this article helpful?

Share it with your network and spread the knowledge!

Advocacy Group Launches Campaign Questioning 340B Drug Pricing Program's Accountability

ADAP Advocacy has launched a national advocacy campaign targeting reforms in the 340B Drug Pricing Program, questioning the program's accountability and potential financial risks. The campaign, titled '340B Too Big To Fail', aims to draw attention to the lack of meaningful oversight in the nation's second-largest federally sponsored drug program.

Brandon M. Macsata, CEO of ADAP Advocacy, compared the current state of the 340B program to the financial market conditions preceding the 2007-2008 economic crisis. The organization's commercial, airing in the Washington, DC metropolitan area, challenges the program's transparency standards, particularly among large hospital systems.

The campaign will explore critical issues including declining hospital charity care, increasing healthcare executive compensation, and the growing burden of patient medical debt. By highlighting these concerns, ADAP Advocacy seeks to prompt congressional and public scrutiny of the drug pricing program's current structure.

Running through the end of the year, the advocacy effort represents a significant challenge to the existing framework of the 340B Drug Pricing Program, potentially signaling a broader conversation about healthcare pricing and institutional accountability.

Curated from 24-7 Press Release

blockchain registration record for this content
Burstable Editorial Team

Burstable Editorial Team

@burstable

Burstable News™ is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.